company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,817539.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,123343.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,60452.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,390227.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1391561.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1391561.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9814.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-66489.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1552228.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1475925.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,84364.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,84364.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-768160.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-683796.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-312741.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-371055.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64579403.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64579403.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37100000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2010.0,Q3,2010-04-01,2010-06-30,2011-08-08 16:08:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,296139.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,296139.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,296139.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,939451.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2261855.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,60452.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,370148.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3631906.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3335767.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-15247.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48826.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,465270.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,529343.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2806424.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2806424.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1574994.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1231430.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,206252.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1437682.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7177941.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q1,2010-10-01,2010-12-31,2012-02-09 16:07:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1241054.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,140658.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,67810.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,362096.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1811618.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1811618.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-35037.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-74827.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,764072.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,724282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1087336.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1087336.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3786718.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2699382.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-205855.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2905237.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7180669.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7891395.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7300000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q2,2011-01-01,2011-03-31,2012-05-08 16:05:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,991368.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,365618.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,66472.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,346707.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1770165.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1770165.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-20531.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-70366.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-124672.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-174507.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1944672.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1944672.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-68742.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2013414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-193497.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1819917.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,7182628.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,7182628.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,7300000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,2011-04-01,2011-06-30,2012-08-13 16:11:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23958.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23958.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23958.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2587601.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,769074.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,454444.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,251878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4062997.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4039039.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-7875.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-106527.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1451112.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1352460.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2686579.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2686579.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-220.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2686799.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-201294.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2485505.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9900000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9900000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10121069.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,2011-10-01,2011-12-31,2013-02-13 16:10:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31250.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31250.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31250.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2947978.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1358691.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,423948.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,169390.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4900007.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4868757.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-5015.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-64261.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-655629.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-714875.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5583632.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5583632.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-483.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5584115.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-248882.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5335233.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10700000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10700000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10663869.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,2012-01-01,2012-03-31,2013-05-09 16:08:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,159016.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,159016.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,159016.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2547099.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1576666.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,449597.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,395675.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4969037.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4810021.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-7416.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-63557.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,85453.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29312.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4780709.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4780709.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-18.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4780727.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-166568.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4614159.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14113620.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,2012-10-01,2012-12-31,2014-02-04 16:33:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2505146.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2125019.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,448765.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,355108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5434038.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5390288.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27567.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-157612.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1364216.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1549395.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6939683.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6939683.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-336.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6940019.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-182082.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6757937.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16461693.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,2013-01-01,2013-03-31,2014-05-06 15:56:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2551362.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1756527.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,454086.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1308047.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,363593.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6433615.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6389865.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48252.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-159530.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,420019.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,212237.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6177628.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6177628.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6177628.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-98618.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6079010.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26400000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26400000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26134183.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,2013-04-01,2013-06-30,2014-08-12 16:00:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2552926.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3247415.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,398964.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1536271.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,307276.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8042852.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7999102.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-68403.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-358352.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5516008.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5805957.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13805059.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13805059.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13805059.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-112876.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13692183.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.57
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.57
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24002224.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q4,2013-07-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4445579.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5216446.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,395779.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1198444.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11256248.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11212498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,109793.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2879995.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2770202.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13982700.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13982700.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13982700.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-40179.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13942521.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44321847.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,2014-01-01,2014-03-31,2015-05-11 16:06:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4036914.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6392200.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,276054.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2038682.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12743850.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12700100.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,305126.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,768523.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1073649.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11626451.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11626451.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11626451.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2468.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11628919.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52900000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52900000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51931989.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,2014-04-01,2014-06-30,2015-08-04 16:02:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,170750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,170750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,170750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5236819.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17744312.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,290039.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2014856.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25286026.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25115276.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,237417.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2302577.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2539994.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22575282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22575282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22575282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22575282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55100000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55100000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54692392.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,2014-10-01,2014-12-31,2016-02-09 16:16:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5238275.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21783580.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,449559.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2205079.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29676493.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29632743.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,198113.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,750637.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,948750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28683993.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28683993.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28683993.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28683993.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55719923.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,2015-01-01,2015-03-31,2016-05-10 16:11:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,123750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,123750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,123750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5399924.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7490400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,741058.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2486074.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16117456.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15993706.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,162366.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-104713.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,57653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15936053.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15936053.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15936053.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15936053.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59492867.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,2015-04-01,2015-06-30,2016-08-09 16:51:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8610174.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10391855.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,855551.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3526888.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1891533.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25276001.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25232251.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,131262.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,357835.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,489097.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24743154.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24745554.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24745554.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24745554.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57358442.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q4,2015-07-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5871495.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10338833.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,794349.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2380343.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19385020.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19341270.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100380.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23524.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,76856.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19264414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19264414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19264414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19264414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59548672.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,2015-10-01,2015-12-31,2017-02-06 16:16:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43750.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8067028.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10020826.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,803912.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2416839.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21308605.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21264855.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,79060.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,369935.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,448995.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20815860.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20815860.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20815860.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20815860.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,59500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,59500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59779128.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,2016-01-01,2016-03-31,2017-05-03 16:13:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39583.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39583.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39583.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6388890.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9423195.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,818200.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2750785.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19381070.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19341487.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34103.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-113359.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79256.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19420743.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19420743.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19420743.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19420743.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60700000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,60700000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,59966955.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,2016-04-01,2016-06-30,2017-08-03 16:11:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31250.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31250.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31250.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3267475.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32334964.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,-2416461.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-7547967.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2050817.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-5862464.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21826364.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21795114.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52251.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-476722.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-424471.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22219585.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22221985.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22221985.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22221985.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61050880.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q4,2016-07-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4365496.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4365496.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4365496.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6130279.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9527051.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1185611.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2424442.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19267383.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14901887.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25148.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2790631.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2815779.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12086108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12086108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12086108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12086108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71100000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71100000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71444600.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,2016-10-01,2016-12-31,2018-02-09 16:11:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8985930.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8985930.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8985930.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3677356.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11438216.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15115572.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6129642.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,108744.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-21659.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,87085.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6042557.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6042557.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6042557.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6042557.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74629855.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,2017-01-01,2017-03-31,2018-05-08 16:11:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9342498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9342498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9342498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3919921.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11136741.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15056662.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5714164.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,131358.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,63065.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,194423.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5519741.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5519741.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5519741.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5519741.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78900000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78900000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74772103.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,2017-04-01,2017-06-30,2018-08-07 16:12:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8713785.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8713785.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8713785.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3771596.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18802458.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,-1185611.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2424442.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18964001.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10250216.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,149878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-629151.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-479273.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10729489.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10731889.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10731889.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10731889.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73898598.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73898598.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73100000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q4,2017-07-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3509821.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3509821.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3509821.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4403551.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12919618.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17323169.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13813348.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,163731.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,450739.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,614470.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13198878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13198878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13198878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13198878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74831415.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74831415.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,2017-10-01,2017-12-31,2019-02-07 16:50:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,650125.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,650125.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,650125.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3681830.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12002354.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15684184.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15034059.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,168346.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18598.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,149748.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14884311.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14884311.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14884311.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14884311.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84083937.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84083937.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82700000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,2018-01-01,2018-03-31,2019-05-08 16:12:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,727375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,727375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,727375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4594441.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12052653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16647094.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15919719.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,313702.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,313702.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15606017.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15606017.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15606017.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15606017.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87634435.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87634435.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86700000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,2018-04-01,2018-06-30,2019-08-05 16:09:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11255000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11255000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11255000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6430229.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15993880.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22424109.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11169109.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,402744.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7493.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,410237.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10758872.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2400.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10761272.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10761272.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10761272.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83638469.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83638469.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83800000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q4,2018-07-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34657896.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34657896.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34657896.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6139709.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17572043.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23711752.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10946144.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1091109.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1091109.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12037253.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12037253.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12037253.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12037253.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91091823.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95590183.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92600000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,2018-10-01,2018-12-31,2020-02-05 16:11:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48148275.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48148275.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48148275.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5338955.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20798628.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26137583.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22010692.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1886290.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1886290.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23896982.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23896982.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23896982.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23896982.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94155407.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98082644.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95600000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,2019-01-01,2019-03-31,2020-05-07 16:12:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42696636.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42696636.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42696636.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4809177.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19291710.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24100887.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18595749.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1739959.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1739959.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20335708.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20335708.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20335708.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20335708.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94935471.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98884744.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96800000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,2019-04-01,2019-06-30,2019-08-05 16:09:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43292770.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43292770.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43292770.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10268416.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23386305.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33654721.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9638049.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2240410.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2240410.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11878459.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,173553.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11704906.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11704906.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11704906.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,93858857.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98607815.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94400000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q4,2019-07-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
